Your browser doesn't support javascript.
loading
The risk-based breast screening (RIBBS) study protocol: a personalized screening model for young women.
Gennaro, Gisella; Bucchi, Lauro; Ravaioli, Alessandra; Zorzi, Manuel; Falcini, Fabio; Russo, Francesca; Caumo, Francesca.
Afiliação
  • Gennaro G; Veneto Institute of Oncology (IOV) IRCCS, Padua, Italy.
  • Bucchi L; Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy. lauro.bucchi@irst.emr.it.
  • Ravaioli A; Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.
  • Zorzi M; SER - Servizio Epidemiologico Regionale e Registri, Azienda Zero, Padua, Italy.
  • Falcini F; Emilia-Romagna Cancer Registry, Romagna Cancer Institute, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) Dino Amadori, Meldola, Forlì, Italy.
  • Russo F; Cancer Prevention Unit, Local Health Authority, Forlì, Italy.
  • Caumo F; Direzione Prevenzione, Sicurezza Alimentare, Veterinaria, Regione del Veneto, Venice, Italy.
Radiol Med ; 129(5): 727-736, 2024 May.
Article em En | MEDLINE | ID: mdl-38512619
ABSTRACT
The optimal mammography screening strategy for women aged 45-49 years is a matter of debate. We present the RIBBS study protocol, a quasi-experimental, prospective, population-based study comparing a risk- and breast density-stratified screening model (interventional cohort) with annual digital mammography (DM) screening (observational control cohort) in a real-world setting. The interventional cohort consists of 10,269 women aged 45 years enrolled between 2020 and 2021 from two provinces of the Veneto Region (northen Italy). At baseline, participants underwent two-view digital breast tomosynthesis (DBT) and completed the Tyrer-Cuzick risk prediction model. Volumetric breast density (VBD) was calculated from DBT and the lifetime risk (LTR) was estimated by including VBD among the risk factors. Based on VBD and LTR, women were classified into five subgroups with specific screening protocols for subsequent screening rounds (1) LTR ≤ 17% and nondense breast biennial DBT; (2) LTR ≤ 17% and dense breast biennial DBT and ultrasound; (3) LTR 17-30% or LTR > 30% without family history of BC, and nondense breast annual DBT; (4) LTR 17-30% or > 30% without family history of BC, and dense breast annual DBT and ultrasound; and (5) LTR > 30% and family history of BC annual DBT and breast MRI. The interventional cohort is still ongoing. An observational, nonequivalent control cohort of 43,000 women aged 45 years participating in an annual DM screening programme was recruited in three provinces of the neighbouring Emilia-Romagna Region. Cumulative incidence rates of advanced BC at three, five, and ten years between the two cohorts will be compared, adjusting for the incidence difference at baseline.Trial registration This study is registered on Clinicaltrials.gov (NCT05675085).
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamografia / Detecção Precoce de Câncer / Densidade da Mama Limite: Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Radiol Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Mamografia / Detecção Precoce de Câncer / Densidade da Mama Limite: Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Revista: Radiol Med Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Itália